The publisher's Medical Devices sector report, “Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Transcatheter Aortic Valve Replacement (TAVR) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Aortic Valve Replacement (TAVR) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Aortic Valve Replacement (TAVR) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Aortic Valve Replacement (TAVR) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transcatheter Aortic Valve Replacement (TAVR) Overview
3 Products under Development
3.1 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
3.2 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Segment
3.3 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
3.4 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
3.5 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
3.6 Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
4 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products under Development by Companies
4.1 Transcatheter Aortic Valve Replacement (TAVR) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
5 Transcatheter Aortic Valve Replacement (TAVR) Companies and Product Overview
6 Transcatheter Aortic Valve Replacement (TAVR)- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Segment
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
- Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
- Transcatheter Aortic Valve Replacement (TAVR) Companies - Pipeline Products by Stage of Development
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
- Glossary
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
- Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
- Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aegis Surgical Limited
- Anteris Technologies Ltd
- AorTx, Inc.
- Arbor Surgical Technologies, Inc.
- Atlas Medical
- Biotronik AG
- Boston Scientific Corp
- Carena Healthcare Ltd
- Chengdu Silara Meditech Inc
- Colibri Heart Valve LLC
- ContiTech (Beijing) Medical Technology Co Ltd
- Daidalos Solutions BV
- Direct Flow Medical Inc (Inactive)
- DSM Dyneema BV
- Dura LLC
- Edwards Lifesciences Corp
- Endoluminal Technology Research LLC
- Florida International University
- Folda LLC
- Foldax Inc
- HLT, Inc.
- JC Medical, Inc.
- JenaValve Technology GmbH
- Jenscare Scientific Co Ltd
- Jinshi Biotechnology (Changshu) Co Ltd
- KOKA Lifesciences Co Ltd
- Lepu Medical Technology (Beijing) Co Ltd
- Mayo Clinic
- Medtronic Plc
- Meril Life Sciences Pvt Ltd
- MicroPort CardioFlow Medtech Corp
- MicroPort MedBot (Shanghai) Co Ltd
- NewMed Medical Co Ltd
- Novogate Medical Ltd.
- NVT AG
- Opsens Inc
- P+F Products + Features GmbH
- Peca Labs Inc
- Peijia Medical Ltd
- Pi-Cardia Ltd
- PolyNova Cardiovascular Inc
- RegenaGraft
- ReValve Med Inc
- SAS Cormove
- Shanghai Healing Medical Instruments Co Ltd
- St. Jude Medical LLC
- Stony Brook University
- Strait Access Technologies (Pty) Ltd
- Symetis SA
- The University of British Columbia
- Thubrikar Aortic Valve, Inc.
- University College London
- University of California San Francisco
- University of Cambridge
- University of Iowa
- University of Pennsylvania
- Vascular Concepts Ltd
- Vascular Innovations Co Ltd
- Venus Medtech Hangzhou Inc
- Xeltis AG
- Youngheartvalve LLC
